Filing Details

Accession Number:
0000950170-25-049813
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-04-02 20:15:27
Reporting Period:
2025-03-31
Filing Date:
2025-04-02
Accepted Time:
2025-04-02 20:15:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1088856 Corcept Therapeutics Inc CORT Pharmaceutical Preparations (2834) 770487658
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1817838 Douglas Joseph Lyon C/O Corcept Therapeutics Incorporated
101 Redwood Shores Parkway
Redwood City CA 94065
See Remarks No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-03-31 35,000 $13.56 44,009 No 4 M Direct
Common Stock Acquisiton 2025-03-31 75,000 $16.52 119,009 No 4 M Direct
Common Stock Acquisiton 2025-03-31 40,000 $15.82 159,009 No 4 M Direct
Common Stock Acquisiton 2025-03-31 50,000 $19.26 209,009 No 4 M Direct
Common Stock Disposition 2025-03-31 162,008 $100.22 47,001 No 4 S Direct
Common Stock Disposition 2025-03-31 32,942 $101.37 14,059 No 4 S Direct
Common Stock Disposition 2025-03-31 5,050 $102.48 9,009 No 4 S Direct
Common Stock Acquisiton 2025-04-01 650 $13.56 9,659 No 4 M Direct
Common Stock Disposition 2025-04-01 650 $114.53 9,009 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock option (right to buy) Disposition 2025-03-31 35,000 $0.00 35,000 $13.56
Common Stock Stock option (right to buy) Disposition 2025-03-31 75,000 $0.00 75,000 $16.52
Common Stock Stock option (right to buy) Disposition 2025-03-31 40,000 $0.00 40,000 $15.82
Common Stock Stock option (right to buy) Disposition 2025-03-31 50,000 $0.00 50,000 $19.26
Common Stock Stock option (right to buy) Disposition 2025-04-01 650 $0.00 650 $13.56
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
56,571 2030-02-07 No 4 M Direct
0 2028-02-07 No 4 M Direct
0 2030-07-13 No 4 M Direct
50,000 2032-02-02 No 4 M Direct
55,921 2030-02-07 No 4 M Direct
Footnotes
  1. Includes 1,232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 372 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 215 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 216 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
  2. The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on August 30, 2024 in effect at the time of this transaction.
  3. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $100.00 to $100.98 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
  4. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $101.00 to $101.90 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
  5. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $102.00 to $102.705 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
  6. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.29 to $114.71 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
  7. Fully exercisable.